Skip to Main Content

Paper Details

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.
Mol Syndromol
3
2021
Author NameAffiliation
Yann HeraultUniversite de Strasbourg, CNRS, INSERM, Institut de Genetique et de Biologie Moleculaire et Cellulaire
William C MobleyUniversity of California-San Diego
Lisa M JacolaSt Jude Children's Research Hospital
Leonard AbbedutoUniversity of California-Davis
  • 1 - 4

Datasets

Release 1.2